Colorimetric assays for evaluation of the mode of action of human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors

Antiviral Chemistry and Chemotherapy

Volumn 9, Issue 2, 1998, Pages 167-176

  Shao, X ^a,d   Rytting, A S ^a   Ekstrand, D H L ^a   Vrang, L ^b   Kallander C F R ^c   Gronowitz, J S ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b MEDIVIR AB   (Sweden)

^c Cavidi AB   (Sweden)

^d INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Carrier bound template primers; HIV AIDS; Non nucleoside analogues; Reverse transcriptase; RT assays; RT inhibitors

Indexed keywords

DELAVIRDINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; COLORIMETRY; DNA TEMPLATE; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR AFFINITY;

EID: 0031900752     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029800900208     Document Type: Article

References (8)

1. Åhgren C, Bäckbro K, Bell FW, Cantrell AS, Clemens M, Colacino JM, Deeter JB, Engelhardt JA, Högberg M, Jaskunas SR, Johansson NG, Jordan CL, Kasher JS, Kinnick MD, Lind P, Lopez C, Morin JM, Muesing JR, Noreen R, Öberg B, Paget CJ, Palkowitz JA, Parrish CA, Pranc P, Rippy MK, Rydergård C, Sahlberg C, Swanson S.Ternansky RJ, Unge T, Vasileff RT, Vrang L, West SJ, Zhang H Se Zhou XX (1995) The PETT series, a new class of potent nonnuclcoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Antimicrobial Agents and Chemotherapy 39:1329-1335.
2. Awad RJK, Corrigan GE, Ekstrand LHD. Thorstensson R, Kallandcr CFR & Gronowitz JS (1997) Measurement of levels of human immunodeficency virus type 1 reverse transcriptase (RT) and RT activity-blocking antibody in human serum by a new standardized colorimetric assay. Journal of Clinical Microbiology 35:1080-1089.
3. Dueweke TJ, Poppe SM, Romero DL, Swaney SM, So AG, Downey KM, Althaus IW, Reusser F, Busso M, Resnick L, Mayers DL, Lane J, Aristoff PA, Thomas RC & Tarpley WG (1993) U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication. Antimicrobial Agents and Chemotherapy 37:1127-1131.
4. Ekstrand DHL, Awad J-K, Källander CFR & Gronowitz JS (1996) A sensitive assay for the quantification of reverse transcriptase activity based on the use of carrier-bound template and nonradioactive-product detection, with special reference to human-immunodeficiency-virus isolation. Biotechnology and Applied Biochemistry 23:95-105.
5. White EL, Buckheit RWJ, Ross LJ, Germany JM, Andries K, Pauwels R, Janssen PAJ, Shannon WM & Chirigos MA (1991) A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates. Antiviral Research 16:257-266.
6. Wu JC, Warren TC, Adams J, Proudfoot J, Skiles J, Raghavan P, Perry C, Potocki I, Farina PR & Grob PM (1991) A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site. Biochemistry 30:2022-2026.
7. Zhang H, Vrang L, Bäckbro K, Unge T, Noreen R & Öberg B (1994) Enzymatic properties and sensitivity to inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase with Glu-138→Arg and Tyr-188→His mutations. Antiviral Research 24:43-57.
8. Zhang H, Vrang L, Bäckbro K, Lind P, Sahlberg C, Unge T & Öberg B (1995) Inhibition of human immunodeficiency virus type l wild-type and mutant reverse transcriptases by the phenyl ethyl thiazolyl thiourea derivatives trovirdine and MSC-127. Antiviral Research 28:331-342.